Lately, the 2021 European Thyroid Association Guidelines on indications for post-surgical radioiodine therapy in differentiated thyroid cancer still consider small tumors with minimal extension as intermediate risk tumors, suggesting that the benefit of RAI therapy is controversial but should be discussed, based on post-operative thyroglobuline and neck ultrasound [30]. Here, TG is linked to differentiated thyroid carcinoma.